Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Pancreas (Late Stage^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Ruralurban

State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 9.8 (9.8, 9.9) N/A 39,638 73.3
Alabama 6 8.1 (7.8, 8.4) 48 (44, 49) 529 63.1
Alaska 6 9.2 (8.2, 10.3) 36 (8, 49) 69 72.7
Arizona 6 8.5 (8.3, 8.8) 45 (37, 48) 797 69.2
Arkansas 6 8.9 (8.5, 9.4) 40 (27, 47) 346 70.0
California 3 9.3 (9.1, 9.4) 34 (28, 39) 4,155 75.0
Colorado 6 8.5 (8.2, 8.9) 44 (36, 48) 552 73.1
Connecticut 3 11.2 (10.8, 11.7) 2 (1, 12) 537 78.3
Delaware 6 10.2 (9.5, 11.0) 17 (1, 36) 144 73.4
Florida 6 9.8 (9.6, 9.9) 27 (20, 31) 3,128 72.3
Georgia 3 10.6 (10.3, 10.9) 9 (4, 19) 1,269 78.6
Hawaii 3 9.9 (9.3, 10.5) 23 (6, 39) 195 74.1
Idaho 3 10.4 (9.7, 11.0) 16 (2, 31) 225 75.5
Illinois 3 10.6 (10.4, 10.9) 8 (3, 17) 1,686 74.8
Iowa 3 10.8 (10.3, 11.3) 7 (1, 20) 447 78.1
Kansas 6 9.0 (8.6, 9.5) 37 (25, 46) 326 75.6
Kentucky 3 10.4 (10.0, 10.8) 14 (4, 25) 598 75.6
Louisiana 3 11.3 (10.9, 11.7) 1 (1, 9) 638 78.4
Maine 6 9.3 (8.7, 9.9) 32 (19, 46) 197 68.6
Maryland 6 9.8 (9.5, 10.1) 24 (15, 33) 747 73.0
Michigan 6 10.4 (10.2, 10.7) 13 (6, 22) 1,390 73.9
Minnesota 6 9.4 (9.1, 9.8) 29 (22, 39) 669 66.8
Mississippi 6 10.2 (9.7, 10.6) 19 (6, 30) 377 73.9
Missouri 6 9.8 (9.5, 10.1) 26 (16, 33) 778 72.8
Montana 6 9.0 (8.3, 9.7) 38 (20, 48) 135 73.5
Nebraska 6 9.3 (8.8, 9.9) 31 (17, 45) 221 71.6
Nevada 6 7.8 (7.4, 8.3) 49 (45, 50) 293 63.9
New Hampshire 6 9.6 (8.9, 10.2) 28 (11, 43) 186 70.9
New Jersey 3 11.1 (10.8, 11.3) 3 (1, 9) 1,307 74.1
New Mexico 3 7.2 (6.7, 7.6) 50 (48, 50) 200 61.9
New York 3 11.0 (10.8, 11.2) 4 (1, 9) 2,840 77.0
North Carolina 6 10.5 (10.2, 10.7) 12 (5, 21) 1,369 76.1
North Dakota 6 8.9 (8.1, 9.9) 39 (15, 49) 83 77.6
Ohio 6 10.1 (9.9, 10.4) 20 (11, 26) 1,572 72.5
Oklahoma 6 8.7 (8.4, 9.1) 42 (31, 48) 420 71.0
Oregon 6 9.3 (9.0, 9.7) 30 (22, 41) 523 72.9
Pennsylvania 6 10.9 (10.7, 11.1) 6 (1, 12) 1,967 75.1
Rhode Island 6 10.0 (9.2, 10.7) 21 (3, 39) 143 74.2
South Carolina 6 9.8 (9.4, 10.1) 25 (15, 34) 669 72.6
South Dakota 6 10.0 (9.1, 10.9) 22 (1, 42) 110 76.5
Tennessee 6 8.7 (8.4, 9.0) 43 (35, 47) 753 67.9
Texas 3 9.2 (9.0, 9.3) 35 (29, 40) 2,715 69.8
Utah 3 8.5 (8.0, 9.0) 46 (34, 49) 244 72.9
Vermont 6 9.3 (8.4, 10.2) 33 (8, 49) 86 72.4
Virginia 6 8.7 (8.5, 9.0) 41 (34, 47) 928 68.6
Washington 5 10.5 (10.2, 10.8) 10 (4, 21) 964 77.4
West Virginia 6 10.2 (9.6, 10.8) 18 (3, 33) 268 75.5
Wisconsin 6 10.5 (10.2, 10.9) 11 (3, 21) 822 73.8
Wyoming 6 8.4 (7.4, 9.4) 47 (24, 50) 62 72.6
District of Columbia 6 10.9 (9.8, 12.1) 5 (1, 34) 73 68.2
Puerto Rico 6 5.2 (4.9, 5.5) N/A 230 62.2
Indiana 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/07/2024 10:06 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.
Source: SEER and NPCR data. For more specific information please see the table.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top